Abbott Labs (ABT) to Report Q2 Earnings on July 16, Growth Insights

Abbott Laboratories (ABT) is set to report its second-quarter earnings on July 16. In Q1, the company's medical device revenue reached approximately $5.5 billion, contributing about 50% of total sales. The FreeStyle Libre platform alone generated roughly $2 billion in sales, with over 7 million users globally. The cardiovascular segment also showed growth, with $578 million in revenue. These figures highlight Abbott's diverse business structure and position in the medical device market, which could impact investor decisions leading up to the earnings announcement.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.